6 employees
Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.
2017
$2.5M
from 1 investors over 1 rounds
Prokaryotics, Inc. raised $2.5M on March 8, 2018
Investors: National Institutes of Health